Claim 1
Xcare produces measurable economic value for a clinic, confirmed in the clinic's own records, at a cost the clinic keeps paying for.
Evidenced (value); retention pending
Why it matters
This is the base of the business and the definition of "patients, not leads." A clinic does not buy marketing; it buys attended new patients, reactivated patients, kept appointments and retained production. If Xcare cannot show that value in the clinic's own PMS — and the clinic does not renew — nothing above this layer matters. It is also the foundation for performance pricing and for every Market economics figure.
Evidence required
Per clinic per month — attended new patients attributed to Xcare; reactivated (overdue → attended) patients; confirmation-driven no-show reduction; clinic-reported production from those patients (or an explicitly labelled external benchmark); Xcare fee and Xcare delivery cost; and, as the revealed-preference test, clinic retention and expansion (second locations, upsells).
Current evidence
Client Report (trailing 18 months, 24 included clinics of 29 active): 2,340 PMS-confirmed attended new patients {ACTUAL}; $9.6M of PMS production attributed to those patients {ACTUAL}; median clinic value ratio 9.0x spend, 96% of clinics >=2x {CALCULATED}; aggregate cost to clinic per attended patient $134, median $216 {CALCULATED}. Two clinics produce approximately 60% of attributed production; one clinic is below 1x; three clinics are excluded pending attribution review.
What would invalidate this claim
A clinic value ratio below ~2× for a majority of clinics over 6+ months, or 12-month logo retention below ~70% with ROI cited as the churn reason.
| Clinic | Model | Attended patients | Value ratio | Cost per attended patient |
|---|---|---|---|---|
| Clinic D-01 | Managed (fixed budget) | 330 | 128.8× | $77 |
| Clinic D-02 | Managed (fixed budget) | 411 | 112.7× | $55 |
| Clinic D-03 | Growth | 138 | 77.7× | $76 |
| Clinic D-04 | Growth | 48 | 37.6× | $286 |
| Clinic D-05 | Managed (fixed budget) | 169 | 30.8× | $143 |
| Clinic D-06 | Growth | 62 | 17.4× | $121 |
| Clinic D-07 | Growth | 53 | 16.2× | $209 |
| Clinic D-08 | Growth | 110 | 14.4× | $197 |
| Clinic D-10 | Growth | 157 | 12.7× | $67 |
| Clinic D-11 | Growth | 27 | 10.9× | $389 |
| Clinic D-12 | Growth | 82 | 10.5× | $128 |
| Clinic D-13 | Managed (fixed budget) | 54 | 10.2× | $222 |
| Clinic D-14 | Growth | 67 | 7.8× | $166 |
| Clinic D-16 | Growth | 46 | 7.3× | $232 |
| Clinic D-17 | Growth | 19 | 6.9× | $711 |
| Clinic D-18 | Growth | 39 | 6.3× | $269 |
| Clinic D-19 | Growth | 212 | 6.1× | $50 |
| Clinic D-20 | Managed (fixed budget) | 35 | 5.7× | $257 |
| Clinic D-21 | Growth | 22 | 4.2× | $489 |
| Clinic D-22 | Growth | 31 | 3.5× | $436 |
| Clinic D-23 | Growth | 13 | 3.4× | $854 |
| Clinic D-24 | Growth | 12 | 3.2× | $920 |
| Clinic D-26 | Growth | 183 | 2.5× | $57 |
| Clinic D-28 | Growth | 20 | 0.6× | $525 |
Attributed production divided by the clinic's spend with Xcare. Log scale; the 1× line is break-even for the clinic and the 2× line is the threshold we hold ourselves to.
Client Report, 2026-09-16, trailing 18 months
3 of 27 clinics with readable counts are excluded pending attribution review (cost per attended patient ≥ $2,700 on ≤5 acquisitions). They are listed, greyed, in the verified evidence table.
| Clinic | Model | Attended patients | Value ratio | Cost per attended patient |
|---|---|---|---|---|
| Clinic D-01 | Managed (fixed budget) | 330 | 128.8× | $77 |
| Clinic D-02 | Managed (fixed budget) | 411 | 112.7× | $55 |
| Clinic D-03 | Growth | 138 | 77.7× | $76 |
| Clinic D-04 | Growth | 48 | 37.6× | $286 |
| Clinic D-05 | Managed (fixed budget) | 169 | 30.8× | $143 |
| Clinic D-06 | Growth | 62 | 17.4× | $121 |
| Clinic D-07 | Growth | 53 | 16.2× | $209 |
| Clinic D-08 | Growth | 110 | 14.4× | $197 |
| Clinic D-10 | Growth | 157 | 12.7× | $67 |
| Clinic D-11 | Growth | 27 | 10.9× | $389 |
| Clinic D-12 | Growth | 82 | 10.5× | $128 |
| Clinic D-13 | Managed (fixed budget) | 54 | 10.2× | $222 |
| Clinic D-14 | Growth | 67 | 7.8× | $166 |
| Clinic D-16 | Growth | 46 | 7.3× | $232 |
| Clinic D-17 | Growth | 19 | 6.9× | $711 |
| Clinic D-18 | Growth | 39 | 6.3× | $269 |
| Clinic D-19 | Growth | 212 | 6.1× | $50 |
| Clinic D-20 | Managed (fixed budget) | 35 | 5.7× | $257 |
| Clinic D-21 | Growth | 22 | 4.2× | $489 |
| Clinic D-22 | Growth | 31 | 3.5× | $436 |
| Clinic D-23 | Growth | 13 | 3.4× | $854 |
| Clinic D-24 | Growth | 12 | 3.2× | $920 |
| Clinic D-26 | Growth | 183 | 2.5× | $57 |
| Clinic D-28 | Growth | 20 | 0.6× | $525 |
One dot per clinic. Median $216, P25 $110, P75 $401; 75% of included clinics are under $400. Log scale.
Client Report, 2026-09-16, trailing 18 months
3 of 27 clinics with readable counts are excluded pending attribution review (cost per attended patient ≥ $2,700 on ≤5 acquisitions). They are listed, greyed, in the verified evidence table.
Full evidence template — verified
Assumptions, risks, data still needed, supporting metrics and charts are available in the Investor Room.
Request access →